Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

From Industry to Generativity: The First 12 Years of the Association for Academic Psychiatry Master Educator Program.

Blitzstein SM, Seritan AL, Sockalingam S, Randall M, Kablinger A, Lieff S, Azzam A.

Acad Psychiatry. 2016 Aug;40(4):576-83. doi: 10.1007/s40596-016-0561-8. Epub 2016 May 2.

PMID:
27137766
2.

Ramelteon-induced nightmares: A case report.

Shah C, Kablinger A.

Asian J Psychiatr. 2015 Dec;18:111-2. doi: 10.1016/j.ajp.2015.09.004. Epub 2015 Sep 21.

PMID:
26427581
3.

Transient agranulocytosis associated with ziprasidone in a 45-year-old man on hemodialysis.

Iskandar JW, Vance JE, Kablinger A, Kavuru B.

J Clin Psychopharmacol. 2015 Jun;35(3):347-8. doi: 10.1097/JCP.0000000000000324. No abstract available.

PMID:
25874914
4.

Controversies in the use of second generation antipsychotics as sleep agent.

Shah C, Sharma TR, Kablinger A.

Pharmacol Res. 2014 Jan;79:1-8. doi: 10.1016/j.phrs.2013.10.005. Epub 2013 Nov 1. Review.

PMID:
24184858
5.

"We cut and drink blood when we have sex. Do we have a problem?" a case report of atypical antipsychotic-treated paraphilia.

Sethi R, Vasudeva S, Saxena A, Kablinger AS.

Prim Care Companion CNS Disord. 2013;15(3). pii: PCC.12l01416. doi: 10.4088/PCC.12l01416. No abstract available.

6.

Training general psychiatry residents to prescribe buprenorphine in treatment of patients with opioid dependence.

Sharma TR, Kablinger AS.

J Grad Med Educ. 2012 Sep;4(3):391. doi: 10.4300/JGME-D-12-00046.1. No abstract available.

7.

Effects of the combination of metyrapone and oxazepam on cocaine craving and cocaine taking: a double-blind, randomized, placebo-controlled pilot study.

Kablinger AS, Lindner MA, Casso S, Hefti F, DeMuth G, Fox BS, McNair LA, McCarthy BG, Goeders NE.

J Psychopharmacol. 2012 Jul;26(7):973-81. doi: 10.1177/0269881111430745. Epub 2012 Jan 11.

PMID:
22236504
8.

Serotonin Syndrome in a Sertraline-Treated Man Taking NyQuil Containing Dextromethorphan for Cold.

Sethi R, Kablinger AS, Kavuru B.

Prim Care Companion CNS Disord. 2012;14(6). pii: PCC.12l01388. doi: 10.4088/PCC.12l01388. No abstract available.

9.

A cytochrome P450 inhibitor in a stable schizophrenic patient: a drug interaction.

Kumar D, Muppa M, Kablinger A.

J Clin Psychopharmacol. 2011 Oct;31(5):670-1. doi: 10.1097/JCP.0b013e31822cd1aa. No abstract available.

PMID:
21881457
10.

Substance use and schizophrenia: adverse correlates in the CATIE study sample.

Kerfoot KE, Rosenheck RA, Petrakis IL, Swartz MS, Keefe RS, McEvoy JP, Stroup TS; CATIE Investigators.

Schizophr Res. 2011 Nov;132(2-3):177-82. doi: 10.1016/j.schres.2011.07.032. Epub 2011 Aug 26.

PMID:
21872443
11.

A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP).

Stroup TS, McEvoy JP, Ring KD, Hamer RH, LaVange LM, Swartz MS, Rosenheck RA, Perkins DO, Nussbaum AM, Lieberman JA; Schizophrenia Trials Network.

Am J Psychiatry. 2011 Sep;168(9):947-56. doi: 10.1176/appi.ajp.2011.10111609. Epub 2011 Jul 18.

12.

Extrapyramidal side-effects of antipsychotics in a randomised trial.

Miller DD, Caroff SN, Davis SM, Rosenheck RA, McEvoy JP, Saltz BL, Riggio S, Chakos MH, Swartz MS, Keefe RS, Stroup TS, Lieberman JA; Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators.

Br J Psychiatry. 2008 Oct;193(4):279-88. doi: 10.1192/bjp.bp.108.050088.

13.

Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia.

Swanson JW, Swartz MS, Van Dorn RA, Volavka J, Monahan J, Stroup TS, McEvoy JP, Wagner HR, Elbogen EB, Lieberman JA; CATIE investigators.

Br J Psychiatry. 2008 Jul;193(1):37-43. doi: 10.1192/bjp.bp.107.042630.

14.

The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study.

Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, Reimherr F, Miller DD, McGee M, Khan A, Canive JM, Davis SM, Hsiao JK, Lieberman JA; CATIE Investigators.

Schizophr Res. 2008 Mar;100(1-3):39-52. doi: 10.1016/j.schres.2007.11.034. Epub 2008 Jan 11.

PMID:
18191383
15.

Multiple sclerosis and behavior.

Pinkston JB, Kablinger A, Alekseeva N.

Int Rev Neurobiol. 2007;79:323-39. Review.

PMID:
17531848
16.

Hereditary ataxia and behavior.

Alekseeva N, Kablinger AS, Pinkston J, Gonzalez-Toledo EC, Minagar A.

Adv Neurol. 2005;96:275-83. Review.

PMID:
16383226
17.

Open trial of pindolol in the treatment of fibromyalgia.

Wood PB, Kablinger AS, Caldito GS.

Ann Pharmacother. 2005 Nov;39(11):1812-6. Epub 2005 Oct 11.

PMID:
16219901
18.

Medications for panic disorder and generalized anxiety disorder during pregnancy.

Rubinchik SM, Kablinger AS, Gardner JS.

Prim Care Companion J Clin Psychiatry. 2005;7(3):100-5.

19.

HIV-associated dementia, Alzheimer's disease, multiple sclerosis, and schizophrenia: gene expression review.

Minagar A, Shapshak P, Duran EM, Kablinger AS, Alexander JS, Kelley RE, Seth R, Kazic T.

J Neurol Sci. 2004 Sep 15;224(1-2):3-17. Review.

PMID:
15450765
20.

Divalproex versus valproate in patients with bipolar disorder.

Kablinger AS, Czerwinski WP, Minagar A.

J Clin Psychopharmacol. 2004 Apr;24(2):231-2. No abstract available.

PMID:
15206673

Supplemental Content

Loading ...
Support Center